The J. Craig Venter Institute announced the launch of Diploid Genomics, an AI‑driven genomics analytics spinout co‑founded by J. Craig Venter with seed investment from Healthier Capital. Diploid plans to combine long‑read sequencing (PacBio, Oxford Nanopore), imaging and AI models to deliver discovery and diagnostic insights, and is building a CLIA‑bound sequencing center in San Diego. The company aims to offer discovery and clinical‑grade sequencing analytics for complex diseases and to pursue partnerships with academic medical centers and industry. The startup highlights ongoing commercialization of advanced genomics coupled with AI analytics.